Investing.com â€“ Denmark stocks were lower after the close on Thursday, as losses in the Healthcare, Personal & Household Goods and Financials sectors led shares lower. At the close in Copenhagen, the OMX Copenhagen 20 declined 1.89%. The best performers of the session on the OMX Copenhagen 20 were  Rockwool International B  (CSE:ROCKb), which rose 6.07% or 184.00 points to trade at 3,214.00 at the close. Meanwhile,  Vestas Wind  Systems A/S (CSE:VWS) added 3.73% or 3.90 points to end at 107.20 and AP Moeller - Maersk A/S A (CSE:MAERSKa) was up 2.08% or 250.00 points to 12,270.00 in late trade. The worst performers of the session were Novozymes A/S B (CSE:NSISb), which fell 5.43% or 23.30 points to trade at 406.00 at the close. Coloplast A/S (CSE:COLOb) declined 4.03% or 31.00 points to end at 738.60 and  Novo Nordisk  A/S Class B (CSE:NOVOb) was down 3.02% or 19.10 points to 612.40. Rising stocks outnumbered declining ones on the Copenhagen Stock Exchange by 74 to 57 and 17 ended unchanged. Shares in Rockwool International B (CSE:ROCKb) rose to 3-years highs; rising 6.07% or 184.00 to 3,214.00. Shares in Coloplast A/S (CSE:COLOb) fell to 52-week lows; down 4.03% or 31.00 to 738.60.  Crude oil for April delivery was down 0.83% or 0.55 to $65.76 a barrel. Elsewhere in commodities trading, Brent oil for delivery in May fell 0.56% or 0.39 to hit $68.91 a barrel, while the April Gold Futures contract fell 0.06% or 1.69 to trade at $2,924.31 a troy ounce. USD/DKK was down 0.36% to 6.89, while EUR/DKK unchanged 0.03% to 7.46. The US Dollar Index Futures was down 0.34% at 103.90. With NOVOb making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed NOVOb alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including NOVOb, could offer substantial returns as the market corrects. In 2024 alone, our AI identified several undervalued stocks that later surged by 30 or more. Is NOVOb poised for similar growth? Don't miss the opportunity to find out. 